Clinical Trial Update: A Study of Camrelizumab Combined With Chemotherapy as Neoadjuvant Therapy in Adcanced Esophageal Squamous Cell Carcinoma (ESCC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating camrelizumab plus chemotherapy as neoadjuvant therapy for advanced esophageal squamous cell carcinoma is underway, with stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Hunan Cancer Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN